Vortrag (26)

141.
Vortrag
Enav, H.: Strain tracking in complex microbiomes using synteny analysis reveals per-species modes of evolution. 5th Ghent Gut Inflammation Group Meeting, Ghent, Belgium (2025)
142.
Vortrag
Huus, K.: Flagellin in the Gut Microbiome is a Diet-Adjustable Adjuvant for Vaccination. BioConnect Seminar: Max Planck Institute for Biology, Tübingen, Germany (2025)
143.
Vortrag
Mbong Ngwese, M.: Expanding the diversity and functional insights of human gut methanogens through cultivation and genomics. BioConnect Seminar: Max Planck Institute for Biology, Tübingen, Germany (2025)
144.
Vortrag
Enav, H.: Differentiating evolution via point mutation or structural change on a per-species basis in complex microbiomes. Institute for Medical Research Israel-Canada Department of Microbiology & Molecular Genetics, Jerusalem, Israel (2024)
145.
Vortrag
Huus, K.: Evolutionary histories and adaptations of human gut microbiota. 3rd International Conference Controlling Microbes to Fight Infections (CMFI 2023), Tübingen, Germany (2023)
146.
Vortrag
Ley, R.: Evolutionary histories and adaptations of human gut microbiota. 3rd International Conference Controlling Microbes to Fight Infections (CMFI 2023), Tübingen, Germany (2023)
147.
Vortrag
Maier, L.: The consequences of drugging the gut microbiome: from the individual microbe to the host. 3rd International Conference Controlling Microbes to Fight Infections (CMFI 2023), Tübingen, Germany (2023)
148.
Vortrag
Ley, R.: Silent flagellins, or how the gut immune system turns a blind eye. EMBO EMBL Symposium: The Human Microbiome , Heidelberg, Germany (2023)
149.
Vortrag
Ley, R.: Humans and their gut microbes: shared evolutionary trajectories and adaptations. Cell Symposia: Infection Biology in the Age of the Microbiome, Paris, France (2023)
150.
Vortrag
Ley, R.: Microbiomes & Microbial Interactions. EMBO EMBL Symposium: New approaches and concepts in microbiology , Heidelberg, Germany (2023)
151.
Vortrag
Ley, R.: Codiversification of humans with gut and oral microbiota and their characteristics. EMBO EMBL Symposium: New approaches and concepts in microbiology , Heidelberg, Germany (2023)
152.
Vortrag
Ley, R.: Humans and their gut microbes: shared evolutionary trajectories and adaptations. Max-Planck-Campus Tübingen: Distinguished Speaker Seminar Series (DSSS), Tübingen, Germany (2023)
153.
Vortrag
Huus, K.: From famine to fever: immunity, diet, and the microbiome. University of Ottawa: Special Seminar Series on Microbiomes, Ottawa, Canada (2022)
154.
Vortrag
Ley, R.: Silent Recognition of Flagellins from Human Gut Commensal Bacteria by Toll-Like Receptor 5. Keystone Symposia: Novel Approaches Against Emerging Antimicrobial Resistance (RQ4), Banff, AB, Canada (2022)
155.
Vortrag
Suzuki, T.: Codiversification of gut microbiota with humans. Keystone Symposia: Novel Approaches Against Emerging Antimicrobial Resistance (RQ4), Banff, AB, Canada (2022)
156.
Vortrag
Marsh, J.: Toward Microbiome Engineering: Expanding the Repertoire of Genetically Tractable Members of the Human Gut Microbiome. New Horizons in Precision Medical Imaging and Therapy Symposium, Tübingen, Germany (2022)
157.
Vortrag
Ley, R.: Silent recognition of flagellin from human gut commensal bacteria by toll-like receptor 5. EMBO EMBL Symposium: Innate immunity in host-pathogen interactions, Heidelberg, Germany (2022)
158.
Vortrag
Ley, R.: The human gut microbiome: ecology and evolution. Bayer Foundation: Boundary Breaking Science Lecture Series (2022)
159.
Vortrag
Suzuki, T.: Codiversification of gut microbiota with humans and the role of microbes in mammalian ecology and evolution. The Center for Ecological Research: CER Seminars, Kyoto, Japan (2021)
160.
Vortrag
Ley, R.: The Interplay Between Host Genetics and the Human Gut Microbiota. San Diego Digestive Diseases Research Center (SDDRC), San Diego, CA, USA (2020)
Zur Redakteursansicht